Antimicrobial stewardship in children: Where to from here?
Antimicrobial resistance (AMR) is an ever‐developing global threat and children are becoming increasingly affected. In addition to established antimicrobial stewardship (AMS) measures, it is important to recognise the need for a paediatric focus to manage the physiological and pathological differenc...
Gespeichert in:
Veröffentlicht in: | Journal of paediatrics and child health 2020-10, Vol.56 (10), p.1504-1507 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1507 |
---|---|
container_issue | 10 |
container_start_page | 1504 |
container_title | Journal of paediatrics and child health |
container_volume | 56 |
creator | Fay, Michael‐John Bryant, Penelope A. |
description | Antimicrobial resistance (AMR) is an ever‐developing global threat and children are becoming increasingly affected. In addition to established antimicrobial stewardship (AMS) measures, it is important to recognise the need for a paediatric focus to manage the physiological and pathological differences unique to children. Most studies on paediatric AMS are drawn from resource‐rich, hospital settings. They support interventions including AMS programmes, bundled groups of interventions, guidelines and education initiatives. These must be tailored to specific institutions, populations and resources as translating interventions between these may not be effective. There are knowledge gaps in paediatric AMS, which pose challenges to designing both interventions and research in this area. These include quantifying antimicrobial consumption, defining AMS outcomes and understanding the development of AMR. Finding answers to fill these gaps needs urgent attention. There is also a need to think outside the box to improve AMS in children. Potential opportunities include intravenous antibiotics at home via hospital‐in‐the‐home programmes, earlier switching to oral antibiotics, repurposing old antibiotics and re‐evaluating children labelled as having antibiotic allergy. Using all of the possibilities available gives us the best chance of staying ahead of the relentless march of AMR in children. |
doi_str_mv | 10.1111/jpc.15209 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2454408613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2453926625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3889-65774cf57f86921ba77c92c9b6411fee6f17b87bb0308f4fc8019da911c5708f3</originalsourceid><addsrcrecordid>eNp10E1LwzAcBvAgipvTg19ACl70UJfXJtlFxvCVgR4Uj6VNE5bRN5OWsW9vZqcHwVzywo-H_B8AzhG8QWFN1626QQxDeQDGiFIYI87oYThDQmMqEByBE-_XEELMmDgGI0KglALjMZjN685WVrkmt1kZ-U5vMlf4lW0jW0dqZcvC6XoWfay001HXRMY1VbS73J6CI5OVXp_t9wl4v797WzzGy5eHp8V8GSsihIwTxjlVhnEjEolRnnGuJFYyTyhCRuvEIJ4LnueQQGGoUQIiWWQSIcV4eCETcDXktq757LXv0sp6pcsyq3XT-xRTFmYWCSKBXv6h66Z3dfjdThGJkwSzoK4HFab23mmTts5WmdumCKa7QtNQaPpdaLAX-8Q-r3TxK38aDGA6gI0t9fb_pPT5dTFEfgGQe3zE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2453926625</pqid></control><display><type>article</type><title>Antimicrobial stewardship in children: Where to from here?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fay, Michael‐John ; Bryant, Penelope A.</creator><creatorcontrib>Fay, Michael‐John ; Bryant, Penelope A.</creatorcontrib><description>Antimicrobial resistance (AMR) is an ever‐developing global threat and children are becoming increasingly affected. In addition to established antimicrobial stewardship (AMS) measures, it is important to recognise the need for a paediatric focus to manage the physiological and pathological differences unique to children. Most studies on paediatric AMS are drawn from resource‐rich, hospital settings. They support interventions including AMS programmes, bundled groups of interventions, guidelines and education initiatives. These must be tailored to specific institutions, populations and resources as translating interventions between these may not be effective. There are knowledge gaps in paediatric AMS, which pose challenges to designing both interventions and research in this area. These include quantifying antimicrobial consumption, defining AMS outcomes and understanding the development of AMR. Finding answers to fill these gaps needs urgent attention. There is also a need to think outside the box to improve AMS in children. Potential opportunities include intravenous antibiotics at home via hospital‐in‐the‐home programmes, earlier switching to oral antibiotics, repurposing old antibiotics and re‐evaluating children labelled as having antibiotic allergy. Using all of the possibilities available gives us the best chance of staying ahead of the relentless march of AMR in children.</description><identifier>ISSN: 1034-4810</identifier><identifier>EISSN: 1440-1754</identifier><identifier>DOI: 10.1111/jpc.15209</identifier><identifier>PMID: 33099822</identifier><language>eng</language><publisher>Australia: John Wiley & Sons Australia, Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents ; antibiotic resistance; antibiotic us; infectious disease ; Antibiotics ; Antimicrobial agents ; Antimicrobial Stewardship ; Child ; Disease control ; Hospitals ; Humans ; low/middle income countries ; Pediatrics ; pharmacology</subject><ispartof>Journal of paediatrics and child health, 2020-10, Vol.56 (10), p.1504-1507</ispartof><rights>2020 Paediatrics and Child Health Division (The Royal Australasian College of Physicians)</rights><rights>2020 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3889-65774cf57f86921ba77c92c9b6411fee6f17b87bb0308f4fc8019da911c5708f3</citedby><cites>FETCH-LOGICAL-c3889-65774cf57f86921ba77c92c9b6411fee6f17b87bb0308f4fc8019da911c5708f3</cites><orcidid>0000-0001-5137-326X ; 0000-0002-5262-5323</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjpc.15209$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjpc.15209$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33099822$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fay, Michael‐John</creatorcontrib><creatorcontrib>Bryant, Penelope A.</creatorcontrib><title>Antimicrobial stewardship in children: Where to from here?</title><title>Journal of paediatrics and child health</title><addtitle>J Paediatr Child Health</addtitle><description>Antimicrobial resistance (AMR) is an ever‐developing global threat and children are becoming increasingly affected. In addition to established antimicrobial stewardship (AMS) measures, it is important to recognise the need for a paediatric focus to manage the physiological and pathological differences unique to children. Most studies on paediatric AMS are drawn from resource‐rich, hospital settings. They support interventions including AMS programmes, bundled groups of interventions, guidelines and education initiatives. These must be tailored to specific institutions, populations and resources as translating interventions between these may not be effective. There are knowledge gaps in paediatric AMS, which pose challenges to designing both interventions and research in this area. These include quantifying antimicrobial consumption, defining AMS outcomes and understanding the development of AMR. Finding answers to fill these gaps needs urgent attention. There is also a need to think outside the box to improve AMS in children. Potential opportunities include intravenous antibiotics at home via hospital‐in‐the‐home programmes, earlier switching to oral antibiotics, repurposing old antibiotics and re‐evaluating children labelled as having antibiotic allergy. Using all of the possibilities available gives us the best chance of staying ahead of the relentless march of AMR in children.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Infective Agents</subject><subject>antibiotic resistance; antibiotic us; infectious disease</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial Stewardship</subject><subject>Child</subject><subject>Disease control</subject><subject>Hospitals</subject><subject>Humans</subject><subject>low/middle income countries</subject><subject>Pediatrics</subject><subject>pharmacology</subject><issn>1034-4810</issn><issn>1440-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1LwzAcBvAgipvTg19ACl70UJfXJtlFxvCVgR4Uj6VNE5bRN5OWsW9vZqcHwVzywo-H_B8AzhG8QWFN1626QQxDeQDGiFIYI87oYThDQmMqEByBE-_XEELMmDgGI0KglALjMZjN685WVrkmt1kZ-U5vMlf4lW0jW0dqZcvC6XoWfay001HXRMY1VbS73J6CI5OVXp_t9wl4v797WzzGy5eHp8V8GSsihIwTxjlVhnEjEolRnnGuJFYyTyhCRuvEIJ4LnueQQGGoUQIiWWQSIcV4eCETcDXktq757LXv0sp6pcsyq3XT-xRTFmYWCSKBXv6h66Z3dfjdThGJkwSzoK4HFab23mmTts5WmdumCKa7QtNQaPpdaLAX-8Q-r3TxK38aDGA6gI0t9fb_pPT5dTFEfgGQe3zE</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Fay, Michael‐John</creator><creator>Bryant, Penelope A.</creator><general>John Wiley & Sons Australia, Ltd</general><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5137-326X</orcidid><orcidid>https://orcid.org/0000-0002-5262-5323</orcidid></search><sort><creationdate>202010</creationdate><title>Antimicrobial stewardship in children: Where to from here?</title><author>Fay, Michael‐John ; Bryant, Penelope A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3889-65774cf57f86921ba77c92c9b6411fee6f17b87bb0308f4fc8019da911c5708f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Infective Agents</topic><topic>antibiotic resistance; antibiotic us; infectious disease</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial Stewardship</topic><topic>Child</topic><topic>Disease control</topic><topic>Hospitals</topic><topic>Humans</topic><topic>low/middle income countries</topic><topic>Pediatrics</topic><topic>pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fay, Michael‐John</creatorcontrib><creatorcontrib>Bryant, Penelope A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of paediatrics and child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fay, Michael‐John</au><au>Bryant, Penelope A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial stewardship in children: Where to from here?</atitle><jtitle>Journal of paediatrics and child health</jtitle><addtitle>J Paediatr Child Health</addtitle><date>2020-10</date><risdate>2020</risdate><volume>56</volume><issue>10</issue><spage>1504</spage><epage>1507</epage><pages>1504-1507</pages><issn>1034-4810</issn><eissn>1440-1754</eissn><abstract>Antimicrobial resistance (AMR) is an ever‐developing global threat and children are becoming increasingly affected. In addition to established antimicrobial stewardship (AMS) measures, it is important to recognise the need for a paediatric focus to manage the physiological and pathological differences unique to children. Most studies on paediatric AMS are drawn from resource‐rich, hospital settings. They support interventions including AMS programmes, bundled groups of interventions, guidelines and education initiatives. These must be tailored to specific institutions, populations and resources as translating interventions between these may not be effective. There are knowledge gaps in paediatric AMS, which pose challenges to designing both interventions and research in this area. These include quantifying antimicrobial consumption, defining AMS outcomes and understanding the development of AMR. Finding answers to fill these gaps needs urgent attention. There is also a need to think outside the box to improve AMS in children. Potential opportunities include intravenous antibiotics at home via hospital‐in‐the‐home programmes, earlier switching to oral antibiotics, repurposing old antibiotics and re‐evaluating children labelled as having antibiotic allergy. Using all of the possibilities available gives us the best chance of staying ahead of the relentless march of AMR in children.</abstract><cop>Australia</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>33099822</pmid><doi>10.1111/jpc.15209</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-5137-326X</orcidid><orcidid>https://orcid.org/0000-0002-5262-5323</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1034-4810 |
ispartof | Journal of paediatrics and child health, 2020-10, Vol.56 (10), p.1504-1507 |
issn | 1034-4810 1440-1754 |
language | eng |
recordid | cdi_proquest_miscellaneous_2454408613 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Anti-Bacterial Agents - therapeutic use Anti-Infective Agents antibiotic resistance antibiotic us infectious disease Antibiotics Antimicrobial agents Antimicrobial Stewardship Child Disease control Hospitals Humans low/middle income countries Pediatrics pharmacology |
title | Antimicrobial stewardship in children: Where to from here? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A58%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20stewardship%20in%20children:%20Where%20to%20from%20here?&rft.jtitle=Journal%20of%20paediatrics%20and%20child%20health&rft.au=Fay,%20Michael%E2%80%90John&rft.date=2020-10&rft.volume=56&rft.issue=10&rft.spage=1504&rft.epage=1507&rft.pages=1504-1507&rft.issn=1034-4810&rft.eissn=1440-1754&rft_id=info:doi/10.1111/jpc.15209&rft_dat=%3Cproquest_cross%3E2453926625%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2453926625&rft_id=info:pmid/33099822&rfr_iscdi=true |